Sera Prognostics Inc
SERA
NASDAQ
Biotechnology
$1.96
USD
-0.05 (-2.49%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $78.71M
Volume 13.5K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
ATRA | Atara Biotherapeutics Inc | $85.42M | - | -96.7% | - | |
FRMM | Forum Markets, Inc | $82.43M | - | - | - | |
GOSS | Gossamer Bio Inc | $81.25M | - | -55.4% | - | |
CRDF | Cardiff Oncology Inc | $79.27M | - | -10.7% | - | |
SERA | Sera Prognostics Inc | $78.71M | - | -50.4% | - | |
ACET | Adicet Bio Inc | $77.89M | - | - | - | |
NMAD | NOMAD Power Solutions, Inc | $76.83M | - | - | - | |
ACRV | Acrivon Therapeutics Inc | $74.48M | - | - | - | |
ELTX | Elicio Therapeutics Inc | $73.92M | - | -91.9% | - |
Top Peer by Growth
Cardiff Oncology Inc
-10.7% YoY Revenue
Best 1-Year Return
Acrivon Therapeutics Inc
+37.6% Return